Position in DERM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,906
New position
Shares Held
16,398
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. DERM ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in DERM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,906 | 16,398 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||